Lily Dara
@lilydaramd
Physician Scientist, practicing Hepatologist & GI. Research focus: mechanistic & translational, DILI, Cell Death, Checkpoint Inhibitor DILI (ILICI), AIH & PBC.
ID: 1293337887203721217
12-08-2020 00:07:40
747 Tweet
891 Takipçi
466 Takip Edilen
DILI harms patients and remains a TOP reason drugs are withdrawn from the market. Recommend this article by Naga Chalasani et al in HEPATOLOGY Journal reviewing preclinical and clinical testing, DILI adjudication during trials, and how regulators approach NDAs. journals.lww.com/hep/Fulltext/9…